Clinical and Radiologic Outcomes of NOVOSIS ( rhBMP ‐2 With Hydroxyapatite Carrier) Grafting for Scaphoid Waist Nonunion: A Preliminary Clinical Study
Orthopaedic Surgery · 2026-07 · 18 (7) · 1350-1358
DOI: 10.1111/os.70347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Surgery, online erschienen am 05.06.2026. Verfasst von Jisu Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Wonju College of Medicine, Yonsei University, Wonju Severance Christian Hospital, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Scaphoid Bone, Bone Morphogenetic Protein 2, Fractures, Ununited, Durapatite. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Scaphoid nonunion remains a challenging problem due to limited vascularity and carpal malalignment. Although autologous bone grafting remains the standard of care, donor‐site morbidity and technical demands can be substantial. NOVOSIS, a composite of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) and a hydroxyapatite (HA) carrier, has shown osteoinductive and osteoconductive potential in other orthopedic applications, but its clinical efficacy in scaphoid nonunion has not been established.
Methods
Seven consecutive patients with scaphoid waist nonunion underwent fixation using two 2.3‐mm headless compression screws and NOVOSIS application between August 2023 and December 2024. All patients were followed for a minimum of 12 months (mean 12.4 months; range 12–14). Clinical outcomes were assessed using visual analogue scale (VAS), range of motion (ROM), and Mayo Wrist Score (MWS). Radiographic parameters included lateral intrascaphoid angle (LISA) and scapholunate angle (SLA). Paired t ‐tests compared pre‐ and postoperative values.
Results
All patients achieved radiographic union at final follow‐up. VAS scores improved from 4.9 ± 1.2 to 0.4 ± 0.8 ( p < 0.001), and MWS from 59.3 ± 7.3 to 94.3 ± 5.4 ( p < 0.001). LISA improved from 51.7° ± 13.6° to 31.5° ± 5.1° ( p = 0.007), and SLA from 65.7° ± 6.8° to 52.2° ± 8.8° ( p = 0.006). No procedure‐related complications, such as infection, ectopic bone formation, or donor‐site morbidity, were observed.
Conclusion
This preliminary clinical series demonstrated that NOVOSIS provided reliable union, functional recovery, and radiographic correction in scaphoid nonunion without donor‐site morbidity. It may serve as a feasible alternative to autologous bone grafting and warrants further validation in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Wonju College of Medicine, Yonsei University, Wonju Severance Christian Hospital, Wonju, Republic of Korea.
ORCID-Profile: Jisu Park
Zitieren
APA
Park, J., Kwon, K. Y., Ahn, H. J., & Oh, J. R. (2026). Clinical and Radiologic Outcomes of NOVOSIS ( rhBMP ‐2 With Hydroxyapatite Carrier) Grafting for Scaphoid Waist Nonunion: A Preliminary Clinical Study. Orthopaedic Surgery, 18(7), 1350-1358. https://doi.org/10.1111/os.70347
Vancouver
Park J, Kwon KY, Ahn HJ, Oh JR. Clinical and Radiologic Outcomes of NOVOSIS ( rhBMP ‐2 With Hydroxyapatite Carrier) Grafting for Scaphoid Waist Nonunion: A Preliminary Clinical Study. Orthopaedic Surgery. 2026;18(7):1350-1358. doi:10.1111/os.70347
BibTeX
@article{Park2026,
author = {Park, Jisu and Kwon, Ki Youn and Ahn, Hyung Joon and Oh, Jin-Rok},
title = {Clinical and Radiologic Outcomes of NOVOSIS ( rhBMP ‐2 With Hydroxyapatite Carrier) Grafting for Scaphoid Waist Nonunion: A Preliminary Clinical Study},
journal = {Orthopaedic Surgery},
year = {2026},
volume = {18},
number = {7},
pages = {1350--1358},
doi = {10.1111/os.70347}
}
EUVIMED